The three most common infectious diseases in poultry are colibacillosis, airsacculitis, and staphylococcal infections. 2, 7 Antimicrobial agents are used in poultry to minimize economic losses due to these diseases 6 and are often selected based on historical efficacy data, cost effectiveness, and drug withdrawal time. 6 Because of increasing resistance to many antimicrobial agents, older less-expensive drugs are becoming less effective in the treatment of infectious diseases of poultry. Ceftiofur, an extended spectrum cephalosporin, has been approved recently for the control of colibacillosis infections or early chick mortality in day-old chicks (Federal Registry: Sep 14, 1992, 57 [178]:4186). The purpose of this study was to compare the activities of ceftiofur and 8 commonly used antimicrobial agents.
In conjunction with a field study conducted in 1989-1990 to determine the optimum dose of ceftiofur, 4 bacterial isolates were obtained from tissues of untreated cull and moribund chicks. The field study was conducted at 12 different locations, using approximately 45,000 chickens. Isolates from tissues of untreated moribund or cull birds were identified at diagnostic laboratories and submitted to our laboratory for minimum inhibitory concentration (MIC) determinations. The following tissues were sampled: yolk sac, air sac, pericardial sac, and liver. When more than 1 tissue from a single chick yielded the same organism, only 1 isolate was used for MIC testing. The MICs were determined for a total of 442 isolates: coagulase-positive Staphylococcus spp. (123- 3 The following antimicrobial agents were tested: ceftiofur, a penicillin G, b gentamicin b erythromycin b tetracycline, b spectinomycin, b lincomycin, a and ciprofloxacin. c Serial 2 fold dilutions ranging from ≤ 0.06 to 64.0 µg/ml were tested. Testing was done using the NCCLS recommended broth microdilution method 3 using cation-supplemented Mueller-Hinton broth. d Ciprofloxacin was used to represent the fluoroquinolones because at the time that the testing was completed (1989-1990) there were no fluoroquinolones approved for use in veterinary medicine.
Against the gram-negative organisms, ceftiofur, gentamicin, and ciprofloxacin were all active ( Table 1) . Ciprofloxacin demonstrated excellent activity against the gram-negative organisms (MIC 90 ≤ 0.06-0.5 µg/ml). However, ciprofloxatin is approved only for use in humans and was used to represent the fluoroquinolones in this study. Although the use of fluoroquinolones in animals has recently been criticized, 1 these data indicate that ciprofloxacin was active against strains of most enteric bacilli. Ceftiofur was active against Klebsiella spp. and E. coli strains (MIC 90 = 0.5 µg/ml) and less active against the Enterobacter spp. (MIC 90 > 64.0 µg/ ml). Gentamicin was less active than ceftiofur (MIC 90 = 32.0 µg/ml) against the E. coli strains tested but was more active when tested against Enterobacter spp. and Klebsiella spp. (MIC 90 = 0.25 µg/ml). The remaining antimicrobials demonstrated limited activity against the gram-negative organisms tested (MIC 90 ≥ 32.0 µg/ml).
Ciprofloxacin was the most active compound against the staphylococci (MIC 90 ≤ 1.0 µg/ml) ( Table 2 ). Ceftiofur was more active against the coagulase-negative staphylococci (MIC 90 = 0.5) than the coagulase-positive staphylococci (MIC 90 = 64.0). The remaining compounds exhibited limited activity against the staphylococci.
In conclusion, ceftiofur exhibited the best activity of the approved compounds tested. Although ciprofloxacin was highly active against the organisms tested in this study, this compound currently is not approved for use in poultry in the USA.
